These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11990064)

  • 1. Glucocorticoids modulate behavioral effects induced by dopaminergic agonists in rats.
    Danilczuk Z; Ossowska G; Wróbel A; Lupina T
    Pol J Pharmacol; 2001; 53(5):467-73. PubMed ID: 11990064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A; Havemann-Reinecke U
    J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats.
    Poleszak E; Malec D
    Pol J Pharmacol; 2000; 52(6):423-9. PubMed ID: 11334236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of (-) deprenyl (selegiline) on different behavioral changes induced by dopamine agonists in the rat.
    Timar J; Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):659-66. PubMed ID: 2908366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone reduces locomotor stimulation induced by dopamine agonists in mice.
    Wróbel A; Zebrowska-Łupina I; Wielosz M
    Pharmacol Rep; 2005; 57(4):451-7. PubMed ID: 16129911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic treatment with dexamethasone on brain dopamine receptors in mice.
    Wróbel A; Nowak G; Ossowska G; Danilczuk Z; Zebrowska-Łupina I; Wielosz M
    Pol J Pharmacol; 2004; 56(4):399-405. PubMed ID: 15520493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour.
    Schwabe K; Enkel T; Klein S; Schütte M; Koch M
    Behav Brain Res; 2004 Aug; 153(1):21-34. PubMed ID: 15219703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
    Sypniewska M
    Pol J Pharmacol Pharm; 1978; 30(6):755-66. PubMed ID: 573471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of amizil and galantamin on the behavioral effects of apomorphine in rats].
    Bandman AL; Andriianov AI
    Biull Eksp Biol Med; 1981 Nov; 92(11):566-9. PubMed ID: 7198494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia.
    Matsuoka T; Sumiyoshi T; Tanaka K; Tsunoda M; Uehara T; Itoh H; Kurachi M
    Brain Res; 2005 Aug; 1053(1-2):131-6. PubMed ID: 16051205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
    Grabowska M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some central effects of opipramol given repeatedly.
    Skuza G; Rogóz Z; Sowińska H
    Pol J Pharmacol Pharm; 1990; 42(5):425-31. PubMed ID: 2098752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
    Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.